For a Forbes article, Michael Awadalla, Executive Vice President Office of Applied Pharmacotherapy, explores different medications for treating type 1 and type 2 diabetes. In the article, he talks about sulfonylureas, dipeptidyl peptidase-4 inhibitors and insulin, including insight on side effects. According to Michael, some of the most common side effects of insulin include weight gain, hypoglycemia and skin irritation at the injection site.
Importantly, when it comes to diabetes, he notes, “Apart from medication, focusing on lifestyle modifications, particularly diet and exercise, plays a crucial role in managing the condition effectively.”
Read the full article on Forbes.com
Share this: